Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...
2024 — More than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most ...
AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.
Striking New Moray Eel Discovered in Central Indo-Pacific River Mouths, Named After God of the Underworld Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less ...
Karen L. Hassenplug, Pharm.D.; Jill S. Burkiewicz, Pharm.D., BCPS; Terri L. Jackson, Ph.D., B.S.Pharm.; Laura R. Peppers, Pharm.D., BCPS Identifying baseline ...
The integration of several new 'omics' techniques enables a multifaceted ... that can also be the possible future target of new anticoagulant and thrombolytic therapies for more personalized ...
What are the best new MMOs? Once as rare as a legendary loot drop, new MMOs seem to be launching every other month these days. MMOs offer near-boundless freedom in a world populated by a vast ...
By Cindi Leive Grady Hendrix’s new novel, “Witchcraft for Wayward Girls,” is a timely look at the mistreatment of women, with a dose of horror, monsters and magic. By Hugh Ryan A powerful ...